Literature DB >> 2420874

Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin.

K Matsushima, M Taguchi, E J Kovacs, H A Young, J J Oppenheim.   

Abstract

The production of interleukin (IL 1) by normal human peripheral blood monocytes purified by Ficoll-Hypaque density sedimentation, Percoll-gradient sedimentation, and plastic adherence can be detected as early as 30 min intracellularly, and extracellularly within 1 hr after stimulation with lipopolysaccharide (LPS). Production of mRNA coding for the isoelectric point 7.0 species of IL 1 was also detected as early as 1 hr after LPS stimulation and reached a maximum level at 6 hr. Cell-associated IL 1 activity could be extracted with CHAPS detergent from every cell fraction (i.e., membranes, cytosol, and particulates), but was present mainly (greater than 95%) in the cytosol of LPS-activated monocytes and the myelomonocytic cell line, THP-1. The apparent m.w. of IL 1 activity on high pressure liquid chromatography gel filtration in every cell fraction was approximately 23,000 daltons, with a minor peak at 31,000 daltons, whereas the IL 1 activity in the culture supernatants was 17,000 daltons. Western blotting analysis of LPS-stimulated monocyte extracts showed two forms of IL 1 corresponding to 31,000 daltons and 25,000 daltons. Exposure of viable cells to trypsin and plasmin released biologically active 23,000 dalton IL 1 only from IL 1-producing cells such as activated monocytes and IL 1-producing Ebstein-Barr virus B lymphocyte cell lines. Consequently, biologically active IL 1 is presumably exposed on the outer surface of cell membranes. Furthermore, IL 1 release by human monocytes in plasminogen-depleted fetal calf serum was considerably decreased. Conversely, supplementation of plasminogen-depleted serum with purified plasminogen restored the IL 1 production, suggesting that plasmin or plasmin-like factors may be involved in the regulation of the release of IL 1 from IL 1-producing cells. In conclusion, the results suggest that IL 1 is rapidly produced, is pooled in the cytosol, and in part is processed by enzymes, is transferred to the plasma membranes, and is then released from the cells. Tissue plasminogen activator and serum enzymes such as plasmin may therefore be involved in the release of IL 1 from IL 1-producing cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420874

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver.

Authors:  Michal Ganz; Timea Csak; Bharath Nath; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2011-11-21       Impact factor: 5.742

2.  Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance.

Authors:  B E Henricson; W R Benjamin; S N Vogel
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1α.

Authors:  Inna S Afonina; Graham A Tynan; Susan E Logue; Sean P Cullen; Michael Bots; Alexander U Lüthi; Emer P Reeves; Noel G McElvaney; Jan P Medema; Ed C Lavelle; Seamus J Martin
Journal:  Mol Cell       Date:  2011-10-21       Impact factor: 17.970

4.  Partial characterization of an interleukin-1-like factor in human gingival crevicular fluid from patients with chronic inflammatory periodontal disease.

Authors:  H Kabashima; K Maeda; Y Iwamoto; T Hirofuji; M Yoneda; K Yamashita; M Aono
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Expression of membrane interleukin 1 by fibroblasts transfected with murine pro-interleukin 1 alpha cDNA.

Authors:  R C Fuhlbrigge; S M Fine; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

6.  Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF.

Authors:  Y Ichinose; J Y Tsao; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells.

Authors:  D H Lovett; A Larsen
Journal:  J Clin Invest       Date:  1988-07       Impact factor: 14.808

Review 8.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

9.  Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis.

Authors:  Christian Stehlik
Journal:  Arthritis Rheum       Date:  2009-12

10.  Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity.

Authors:  R H Widen; C A Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.